Cleared Special

K163701 - Direxion and Direxion HI-FLO Torqueable...

K163701 is the FDA 510(k) clearance for Direxion and Direxion HI-FLO Torqueable... by Boston Scientific Corporation. It is a Class 2 Cardiovascular device (product code KRA) cleared through the Special 510(k) pathway after a 138-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2017
Decision
138d
Days
Class 2
Risk

K163701 is an FDA 510(k) clearance for the Direxion and Direxion HI-FLO Torqueable Microcatheters. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Boston Scientific Corporation (Maple Grove, US). The FDA issued a Cleared decision on May 16, 2017 after a review of 138 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific Corporation devices

Submission Details

510(k) Number K163701 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 29, 2016
Decision Date May 16, 2017
Days to Decision 138 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d slower than avg
Panel avg: 125d · This submission: 138d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 127
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K163701.
Microcatheter and guide-wire system
K171665 · Suzhou Hengrui Disheng Medical Co., Ltd. · Jan 2018
CXI TriForce Peripheral Crossing Set
K170931 · Cook Incorporated · Nov 2017
Maestro Microcatheter
K172081 · Merit Medical Systems, Inc. · Aug 2017
VAMP Venous/Arterial Blood Management Protection System
K161962 · Edwards Lifesciences, LLC · Nov 2016
CXI Support Catheter
K160884 · Cook Incorporated · Nov 2016
SwiftNINJA Microcatheter
K161921 · Merit Medical Systems, Inc. · Nov 2016